BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4047002)

  • 1. Two-dimensional dose distribution of 125I seeds.
    Ling CC; Schell MC; Yorke ED; Palos BB; Kubiatowicz DO
    Med Phys; 1985; 12(5):652-5. PubMed ID: 4047002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetric effects of seed anisotropy and interseed attenuation for 103Pd and 125I prostate implants.
    Chibani O; Williamson JF; Todor D
    Med Phys; 2005 Aug; 32(8):2557-66. PubMed ID: 16193786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of the radial function on I-125 seeds used for permanent prostate implantation.
    Pickett B; Pouliot J
    Med Dosim; 2004; 29(3):204-9. PubMed ID: 15324917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose rate constant and energy spectrum of interstitial brachytherapy sources.
    Chen Z; Nath R
    Med Phys; 2001 Jan; 28(1):86-96. PubMed ID: 11213926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diode dosimetry of models 6711 and 6712 125I seeds in a water phantom.
    Ahmad M; Fontenla DP; Chiu-Tsao ST; Chui CS; Reiff JE; Anderson LL; Huang DY; Schell MC
    Med Phys; 1992; 19(2):391-9. PubMed ID: 1584138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of seed anisotrophy on brachytherapy dose distributions using 125I and 103Pd.
    Lindsay P; Battista J; Van Dyk J
    Med Phys; 2001 Mar; 28(3):336-45. PubMed ID: 11318315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor dose specification of I-125 seed implants.
    Wu A; Zwicker RD; Sternick ES
    Med Phys; 1985; 12(1):27-31. PubMed ID: 3974522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Near-field dosimetry of 125I sources for interstitial brachytherapy implants measured using thermoluminescent sheets.
    Iwata K; Yue NJ; Nath R
    Med Phys; 2004 Dec; 31(12):3406-16. PubMed ID: 15651623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the dose distribution for prostate implants using various 125I and 103Pd sources.
    Meigooni AS; Luerman CM; Sowards KT
    Med Phys; 2009 Apr; 36(4):1452-8. PubMed ID: 19472652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interseed effects on dose for 125I brachytherapy implants.
    Meigooni AS; Meli JA; Nath R
    Med Phys; 1992; 19(2):385-90. PubMed ID: 1584137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-sensitivity GafChromic film dosimetry for 125I seed.
    Chiu-Tsao ST; de la Zerda A; Lin J; Kim JH
    Med Phys; 1994 May; 21(5):651-7. PubMed ID: 7935199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose rate determination for 125I seeds.
    Chiu-Tsao ST; Anderson LL; O'Brien K; Sanna R
    Med Phys; 1990; 17(5):815-25. PubMed ID: 2233567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idealized line source configuration for permanent 125I prostate implants.
    Leclerc G; Lavallée MC; Tubic D; Métivier J; Vigneault E; Beaulieu L
    Radiother Oncol; 2004 Aug; 72(2):213-20. PubMed ID: 15297139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental measurements of dosimetric parameters on the transverse axis of a new 125I source.
    Li Z; Fan JJ; Palta JR
    Med Phys; 2000 Jun; 27(6):1275-80. PubMed ID: 10902556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of anisotropic data in 125I prostate implants.
    Fox RA; Haworth A; Mina LL
    Australas Phys Eng Sci Med; 1997 Jun; 20(2):57-63. PubMed ID: 9262024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetry for 125I seed (model 6711) in eye plaques.
    Chiu-Tsao ST; Anderson LL; O'Brien K; Stabile L; Liu JC
    Med Phys; 1993; 20(2 Pt 1):383-9. PubMed ID: 8497229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monte Carlo calculated TG-43 dosimetry parameters for the SeedLink 125Iodine brachytherapy system.
    Medich DC; Munro JJ
    Med Phys; 2003 Sep; 30(9):2503-8. PubMed ID: 14528972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dosimetry of 125I seed eye plaques.
    Weaver KA
    Med Phys; 1986; 13(1):78-83. PubMed ID: 3814235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a new brachytherapy iodine-125 source by AAPM TG43 formalism.
    Wallace RE; Fan JJ
    Med Phys; 1998 Nov; 25(11):2190-6. PubMed ID: 9829244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermoluminescent dosimetry of the SourceTech Medical model STM1251 125I seed.
    Chiu-Tsao ST; Duckworth TL; Hsiung CY; Li Z; Williamson J; Patel NS; Harrison LB
    Med Phys; 2003 Jul; 30(7):1732-5. PubMed ID: 12906190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.